Top1031

W Pharmacy I DST

sponsored by Inland Private Capital

HistoricalLast Form D, filed Mar 4, 2013, reports the offering fully sold (opens in a new tab)

W Pharmacy I DST, sponsored by Inland Private Capital, filed its first Form D with the SEC on Nov 2, 2012 for a $13.8 million offering. Its last Form D, filed Mar 4, 2013, reports the offering fully sold.

How it ended

No public outcome found

The last Form D, filed Mar 4, 2013, reports the offering fully sold.

Inland Private Capital has 8 active offerings on record →

Key facts

Minimum investment
$25,000
From the Form D
Offering size
$13,430,703
Equity offered, per the Form D
Sold
100%
Form D, Mar 4, 2013; the % is our arithmetic
Investors reported
35
Form D, Mar 4, 2013
Selling commissions
$967,761 · 7.2% of offering
Form D Item 15; the % is our arithmetic
Financing
Leveraged. This offering reports mortgage debt on the property.
How it is financed ↓
Offered under
Rule 506(b)
General advertising and solicitation are not permitted under this exemption.

Figures come from SEC Form D filings unless a source is cited. Sponsor-stated figures are as reported by the sponsor; Top1031 does not independently audit them. On a 45-day clock? Find day 45 and day 180 →

Using this record to judge the sponsor? A licensed 1031 specialist from our affiliated partner can talk it through with you.

Ask a 1031 specialist about this recordFree. About: W Pharmacy I DST. Top1031 is not a broker-dealer.

What did W Pharmacy I DST own?

The public record does not identify what this Trust owns. Its Form D describes only beneficial interests in a Delaware Statutory Trust reflecting beneficial interests in real estate, without naming an asset, address, tenant, or square footage. 1 The name points toward a pharmacy property, but no source located during research ties this specific Trust to a building or operator.

How was it financed, and what did it cost to sell?

Debt

Financing
Leveraged. This offering reports mortgage debt on the property.

Costs and terms from the Form D

Selling commissions
$967,761 · 7.2% of offering
Finders’ fees
$0
Paid to officers, directors and promoters
$1,591,910 · 11.8% of offering
Form D Item 16
Broker-dealers named in the Form D
15 named in the Form D
Show the firms

Individual representatives named in Item 12 are not listed.

Date of first sale
Oct 25, 2012
Minimum investment
$25,000

Form D Item 15 and Item 16 amounts may be the issuer’s estimates; each percentage is Top1031’s arithmetic on two Form D figures. Item 16 can overlap Item 15, so Top1031 does not add them together. The issuer marked these amounts as an estimate.

What does the SEC record show?

This was a private placement: no general advertising, with interests sold only to accredited investors through the sponsor's channels. The initial Form D reported a first sale on October 25, 2012, and each later amendment stepped the reported progress forward. 2 The last amendment reduced the stated offering size to match what had actually been raised. 1

Legal Trust name
W Pharmacy I DST
SEC CIK
1561228
First Form D
Nov 2, 2012
Latest Form D
Mar 4, 2013
Filings on record
8
Offered under
Rule 506(b)
General advertising and solicitation are not permitted under this exemption.
Source filing
Read the filings on SEC EDGAR

SEC Form D filings, newest first

FiledFormOffering amountAmount soldInvestors
Form D/A$13,430,703was $13,825,153
$13,430,703+$150,875
35−1
EDGAR
Form D/A$13,825,153
$13,279,828+$973,723
36+4
EDGAR
Form D/A$13,825,153
$12,306,105+$714,036
32+3
EDGAR
Form D/A$13,825,153
$11,592,069+$4,512,462
29+8
EDGAR
Form D/A$13,825,153
$7,079,607+$544,790
21+5
EDGAR
Form D/A$13,825,153
$6,534,817+$5,349,058
16+11
EDGAR
Form D/A$13,825,153
$1,185,759+$886,633
5+3
EDGAR
Form D$13,825,153
$299,126
2
EDGAR

Amounts, investor counts and minimums are as filed with the SEC on Form D. The change lines are Top1031’s arithmetic between consecutive filings; a new Form D notice starts a new count.

A Form D is the notice a sponsor files when it starts raising money. A Form D filing does not mean the SEC approved, endorsed, or verified the offering.

Common questions

What happened to W Pharmacy I DST?
W Pharmacy I DST is a Historical offering. The last Form D, filed Mar 4, 2013, reports the offering fully sold.
Does the "W" in the name mean Walgreens?
That is unconfirmed. Similarly named Inland offerings — Pharmacy Portfolio, Pharmacy Portfolio II and VI, and Pharmacy Sale Leaseback II — identify different trusts and were excluded from this record. No located source ties W Pharmacy I DST to a specific pharmacy operator.
Has the Trust sold its property or been liquidated?
No outcome has been reported in any source located. There is no public record of a sale, a 721/UPREIT roll-up into a REIT operating partnership, a refinancing, or a distress event for this specific Trust. The SEC filing record ends with the March 4, 2013 amendment.
Why are there eight filings for one offering?
Form D issuers file an initial notice and then amendments as facts change. Here the initial November 2, 2012 notice was followed by seven amendments over roughly four months, each restating sales progress and investor count, with the final one adjusting the stated offering amount.

Sources

Show sources (2)Hide sources (2)

These links support the record as a whole; individual details may come from different sources.

DST interests are illiquid private securities. You may lose some or all of your investment. Distributions, tax treatment, and exit timing are not guaranteed. Review the current offering documents before investing.